Cancer burden in the year 2000. The global picture, European Journal of Cancer, vol.37, p.66, 2001. ,
DOI : 10.1016/S0959-8049(01)00267-2
The development of androgen-independent prostate cancer, Nature Reviews Cancer, vol.1, issue.1, pp.34-45, 2001. ,
DOI : 10.1038/35094009
Oncogenes and Tumor Suppressor Genes in Prostate Cancer, Epidemiologic Reviews, vol.23, issue.1, pp.36-41, 2001. ,
DOI : 10.1093/oxfordjournals.epirev.a000794
FINDING PROSTATE CANCER SUSCEPTIBILITY GENES, Annual Review of Genomics and Human Genetics, vol.5, issue.1, pp.151-75, 2004. ,
DOI : 10.1146/annurev.genom.5.061903.180044
Molecular Mechanisms of Prostate Cancer, European Urology, vol.45, issue.6, pp.683-91, 2004. ,
DOI : 10.1016/j.eururo.2004.01.012
Use of multiple biomarkers for a molecular diagnosis of prostate cancer, International Journal of Cancer, vol.18, issue.3, pp.950-956, 2005. ,
DOI : 10.1002/ijc.20760
Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR, International Journal of Cancer, vol.94, issue.2, pp.174-81, 2005. ,
DOI : 10.1002/ijc.20704
Chinnaiyan AM: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, issue.5748, pp.310644-310652, 2005. ,
Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23, Clin Cancer Res, vol.2, issue.6, pp.1039-1087, 1996. ,
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling, Oncogene, vol.20, issue.46, pp.206718-206741, 2001. ,
DOI : 10.1038/sj.onc.1204889
Use of nude mouse xenograft models in prostate cancer research, The Prostate, vol.20, issue.4, pp.263-271, 2000. ,
DOI : 10.1002/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I
Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nature Medicine, vol.54, issue.7, pp.844-847, 1998. ,
DOI : 10.1023/A:1005769925670
FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers, Genes, Chromosomes and Cancer, vol.4, issue.4, pp.219-226, 1993. ,
DOI : 10.1002/gcc.2870070407
Gene expression profiles of poor-prognosis primary breast cancer correlate with survival, Human Molecular Genetics, vol.11, issue.8, pp.11863-72, 2002. ,
DOI : 10.1093/hmg/11.8.863
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease, Oncogene, vol.21, issue.19, pp.3095-3102, 2002. ,
DOI : 10.1038/sj.onc.1205418
Cluster analysis and display of genome-wide expression patterns, Proceedings of the National Academy of Sciences, vol.24, issue.2, pp.9514863-14868, 1998. ,
DOI : 10.1016/0092-8674(81)90326-3
High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer, The American Journal of Pathology, vol.157, issue.3, pp.787-794, 2000. ,
DOI : 10.1016/S0002-9440(10)64592-0
Expression scanning of an array of growth control genes in human tumor cell lines, Oncogene, vol.18, issue.26, pp.183905-3912, 1999. ,
DOI : 10.1038/sj.onc.1202731
Gene amplifications associated with the development of hormone-resistant prostate cancer, Clin Cancer Res, vol.9, issue.14, pp.5271-81, 2003. ,
Protein expression profiling identifies subclasses of breast cancer and predicts prognosis, Cancer Res, issue.3, pp.65767-79, 2005. ,
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression, Cancer Cell, vol.8, issue.5, pp.393-406, 2005. ,
DOI : 10.1016/j.ccr.2005.10.001
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1, Cancer Res, issue.21, pp.606134-606138, 2000. ,
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays, Cancer Res, issue.5, pp.621256-60, 2002. ,
Fibroblast growth factor receptor 2 limits and receptor 1 acceleratestumorigenicity of prostate epithelial cells, Cancer Res, vol.57, issue.23, pp.5369-78, 1997. ,
Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer, Virchows Archiv, vol.12, issue.2, pp.68-74, 2005. ,
DOI : 10.1007/s00428-005-0075-3
Expression of Melan-A (MART1) in Benign Melanocytic Nevi and Primary Cutaneous Malignant Melanoma, The American Journal of Surgical Pathology, vol.22, issue.8, pp.22976-82, 1998. ,
DOI : 10.1097/00000478-199808000-00007
False-positive Rate of the Immunoperoxidase Stains for MART1/MelanA in Lymph Nodes, The American Journal of Surgical Pathology, vol.28, issue.5, pp.596-600, 2004. ,
DOI : 10.1097/00000478-200405000-00005
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy, Cancer Res, vol.59, issue.2, pp.301-307, 1999. ,
D-TACC: a novel centrosomal protein required for normal spindle function in the early Drosophila embryo, The EMBO Journal, vol.20, issue.2, pp.241-52, 2000. ,
DOI : 10.1093/emboj/19.2.241
Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon, Oncogene, vol.18, issue.27, pp.4032-4040, 1999. ,
DOI : 10.1038/sj.onc.1202801
The Third Member of the Transforming Acidic Coiled Coil-Containing Gene Family, TACC3, Maps in 4p16, Close to Translocation Breakpoints in Multiple Myeloma, and Is Upregulated in Various Cancer Cell Lines, Genomics, vol.58, issue.2, pp.165-70, 1999. ,
DOI : 10.1006/geno.1999.5829
AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression, Molecular Biology of the Cell, vol.11, issue.4, pp.1357-67, 2000. ,
DOI : 10.1091/mbc.11.4.1357
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes, Oncogene, vol.18, issue.10, pp.181903-181913, 1999. ,
DOI : 10.1038/sj.onc.1202739
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators, Oncogene, vol.21, issue.36, pp.5619-5649, 2002. ,
DOI : 10.1038/sj.onc.1205658
A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1., Proceedings of the National Academy of Sciences, vol.90, issue.19, pp.908896-900, 1993. ,
DOI : 10.1073/pnas.90.19.8896
Regulation of insulin-like growth factor I receptor gene expression by the wilms??? tumor supressor WT1, Journal of Molecular Neuroscience, vol.169, issue.2, pp.111-134, 1996. ,
DOI : 10.1007/BF02736791
The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor, Clin Cancer Res, vol.3, issue.12, pp.2571-80, 1997. ,
The Wilms??? tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes, Leukemia, vol.13, issue.3, pp.393-402, 1999. ,
DOI : 10.1038/sj.leu.2401341
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry, Leukemia, vol.16, issue.7, pp.161381-161390, 2002. ,
DOI : 10.1038/sj.leu.2402512
Expression of theWT1 Wilms' tumor gene by normal and malignant human melanocytes, International Journal of Cancer, vol.83, issue.1, pp.78-82, 1994. ,
DOI : 10.1002/ijc.2910590116
Molecular mechanisms possibly affecting WT1 function in human ovarian tumors, International Journal of Cancer, vol.90, issue.4, pp.515-536, 1994. ,
DOI : 10.1002/ijc.2910570413
High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse longterm outcome, pp.901217-901242, 1997. ,
The role of Wilms' tumor genes, J Med Invest, vol.46, pp.3-4130, 1999. ,
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1, Anticancer Res, vol.21, issue.1A, pp.1-10 ,